<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en" dir="ltr">
  <head>
    <meta http-equiv="Content-Type" content="text/html; charset=UTF-8" />
    		<meta name="keywords" content="Angiogenesis,Aerobic exercise,Ang1,Ang2,Angiogenesis inhibitor,Angiopoietins,Angiostatin,Arteriogenesis,Avastin,BFGF,Blood vessel" />
		<link rel="shortcut icon" href="/favicon.ico" />
		<link rel="search" type="application/opensearchdescription+xml" href="/w/opensearch_desc.php" title="Wikipedia (English)" />
		<link rel="copyright" href="../../../COPYING.html" />
    <title>Angiogenesis - Wikipedia, the free encyclopedia</title>
    <style type="text/css">/*<![CDATA[*/ @import "../../../skins/htmldump/main.css"; /*]]>*/</style>
    <link rel="stylesheet" type="text/css" media="print" href="../../../skins/common/commonPrint.css" />
    <!--[if lt IE 5.5000]><style type="text/css">@import "../../../skins/monobook/IE50Fixes.css";</style><![endif]-->
    <!--[if IE 5.5000]><style type="text/css">@import "../../../skins/monobook/IE55Fixes.css";</style><![endif]-->
    <!--[if IE 6]><style type="text/css">@import "../../../skins/monobook/IE60Fixes.css";</style><![endif]-->
    <!--[if IE]><script type="text/javascript" src="../../../skins/common/IEFixes.js"></script>
    <meta http-equiv="imagetoolbar" content="no" /><![endif]-->
    <script type="text/javascript" src="../../../skins/common/wikibits.js"></script>
    <script type="text/javascript" src="../../../skins/htmldump/md5.js"></script>
    <script type="text/javascript" src="../../../skins/htmldump/utf8.js"></script>
    <script type="text/javascript" src="../../../skins/htmldump/lookup.js"></script>
    <script type="text/javascript" src="../../../raw/gen.js"></script>        <style type="text/css">/*<![CDATA[*/
@import "../../../raw/MediaWiki%7ECommon.css";
@import "../../../raw/MediaWiki%7EMonobook.css";
@import "../../../raw/gen.css";
/*]]>*/</style>          </head>
  <body
    class="ns-0">
    <div id="globalWrapper">
      <div id="column-content">
	<div id="content">
	  <a name="top" id="contentTop"></a>
	        <h1 class="firstHeading">Angiogenesis</h1>
	  <div id="bodyContent">
	    <h3 id="siteSub">From Wikipedia, the free encyclopedia</h3>
	    <div id="contentSub"></div>
	    	    	    <!-- start content -->
	    <p><b>Angiogenesis</b> is a physiological process involving the growth of new <a href="../../../b/l/o/Blood_vessel.html" title="Blood vessel">blood vessels</a> from pre-existing vessels. Though there has been some debate over this, <a href="../../../v/a/s/Vasculogenesis.html" title="Vasculogenesis">vasculogenesis</a> is the term used for spontaneous blood-vessel formation, and <a href="../../../i/n/t/Intussusception_%28blood_vessel_growth%29.html" title="Intussusception (blood vessel growth)">intussusception</a> is the term for new blood vessel formation by splitting off existing ones.</p>
<p>Angiogenesis is a normal process in growth and development, as well as in wound healing. However, this is also a fundamental step in the transition of <a href="../../../t/u/m/Tumor.html" title="Tumor">tumors</a> from a dormant state to a <a href="../../../m/a/l/Malignant.html" title="Malignant">malignant</a> state.</p>
<table id="toc" class="toc" summary="Contents">
<tr>
<td>
<div id="toctitle">
<h2>Contents</h2>
</div>
<ul>
<li class="toclevel-1"><a href="#Types_of_angiogenesis"><span class="tocnumber">1</span> <span class="toctext">Types of angiogenesis</span></a>
<ul>
<li class="toclevel-2"><a href="#Sprouting_angiogenesis"><span class="tocnumber">1.1</span> <span class="toctext">Sprouting angiogenesis</span></a></li>
<li class="toclevel-2"><a href="#Intussusceptive_angiogenesis"><span class="tocnumber">1.2</span> <span class="toctext">Intussusceptive angiogenesis</span></a></li>
<li class="toclevel-2"><a href="#Therapeutic_angiogenesis"><span class="tocnumber">1.3</span> <span class="toctext">Therapeutic angiogenesis</span></a></li>
</ul>
</li>
<li class="toclevel-1"><a href="#Mechanical_stimulation"><span class="tocnumber">2</span> <span class="toctext">Mechanical stimulation</span></a></li>
<li class="toclevel-1"><a href="#Stimulation_by_protein_growth_factors"><span class="tocnumber">3</span> <span class="toctext">Stimulation by protein growth factors</span></a>
<ul>
<li class="toclevel-2"><a href="#VEGF"><span class="tocnumber">3.1</span> <span class="toctext">VEGF</span></a></li>
<li class="toclevel-2"><a href="#ANGIOPOIETINS"><span class="tocnumber">3.2</span> <span class="toctext">ANGIOPOIETINS</span></a></li>
<li class="toclevel-2"><a href="#MMP"><span class="tocnumber">3.3</span> <span class="toctext">MMP</span></a></li>
<li class="toclevel-2"><a href="#FGF"><span class="tocnumber">3.4</span> <span class="toctext">FGF</span></a></li>
<li class="toclevel-2"><a href="#DII4"><span class="tocnumber">3.5</span> <span class="toctext">DII4</span></a></li>
</ul>
</li>
<li class="toclevel-1"><a href="#Applications_of_Angiogenesis"><span class="tocnumber">4</span> <span class="toctext">Applications of Angiogenesis</span></a>
<ul>
<li class="toclevel-2"><a href="#Tumor_angiogenesis"><span class="tocnumber">4.1</span> <span class="toctext">Tumor angiogenesis</span></a></li>
<li class="toclevel-2"><a href="#Exercise"><span class="tocnumber">4.2</span> <span class="toctext">Exercise</span></a></li>
<li class="toclevel-2"><a href="#Macular_degeneration"><span class="tocnumber">4.3</span> <span class="toctext">Macular degeneration</span></a></li>
</ul>
</li>
<li class="toclevel-1"><a href="#See_also"><span class="tocnumber">5</span> <span class="toctext">See also</span></a></li>
<li class="toclevel-1"><a href="#References"><span class="tocnumber">6</span> <span class="toctext">References</span></a></li>
<li class="toclevel-1"><a href="#External_links"><span class="tocnumber">7</span> <span class="toctext">External links</span></a></li>
</ul>
</td>
</tr>
</table>
<script type="text/javascript">
//<![CDATA[
 if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } 
//]]>
</script>
<p><a name="Types_of_angiogenesis" id="Types_of_angiogenesis"></a></p>
<h2><span class="editsection">[<a href="../../../a/n/g/Angiogenesis.html" title="Edit section: Types of angiogenesis">edit</a>]</span> <span class="mw-headline">Types of angiogenesis</span></h2>
<p><a name="Sprouting_angiogenesis" id="Sprouting_angiogenesis"></a></p>
<h3><span class="editsection">[<a href="../../../a/n/g/Angiogenesis.html" title="Edit section: Sprouting angiogenesis">edit</a>]</span> <span class="mw-headline">Sprouting angiogenesis</span></h3>
<p>Sprouting angiogenesis was the first identified form of angiogenesis. It occurs in several well-characterized stages. First, biological signals known as angiogenic growth factors activate receptors present on endothelial cells present in pre-existing venular blood vessels. Second, the activated endothelial cells begin to release <a href="../../../e/n/z/Enzyme.html" title="Enzyme">enzymes</a> called <a href="../../../p/r/o/Protease.html" title="Protease">proteases</a> that degrade the basement membrane in order to allow endothelial cells to escape from the original (parent) vessel walls. The <a href="../../../e/n/d/Endothelial_cell.html" title="Endothelial cell">endothelial cells</a> then proliferate into the surrounding matrix and form solid sprouts connecting neighboring vessels. As sprouts extend toward the source of the angiogenic stimulus, endothelial cells migrate in tandem, using adhesion molecules, the equivalent of cellular grappling hooks, called <a href="../../../i/n/t/Integrin.html" title="Integrin">integrins</a>. These sprouts then form loops to become a full-fledged vessel <a href="../../../l/u/m/Lumen.html" title="Lumen">lumen</a> as cells migrate to the site of angiogenesis. Sprouting occurs at a rate of several millimeters per day, and enables new vessels to grow across gaps in the vasculature. It is markedly different from splitting angiogenesis, however, because it forms entirely new vessels as opposed to splitting existing vessels <sup id="_ref-Burri2004_0" class="reference"><a href="#_note-Burri2004" title="">[1]</a></sup>.</p>
<p><a name="Intussusceptive_angiogenesis" id="Intussusceptive_angiogenesis"></a></p>
<h3><span class="editsection">[<a href="../../../a/n/g/Angiogenesis.html" title="Edit section: Intussusceptive angiogenesis">edit</a>]</span> <span class="mw-headline">Intussusceptive angiogenesis</span></h3>
<p>Intussusception, also known as splitting angiogenesis, was first observed in neonatal rats. In this type of vessel formation, the capillary wall extends into the <a href="../../../l/u/m/Lumen_%28anatomy%29.html" title="Lumen (anatomy)">lumen</a> to split a single vessel in two. There are four phases of intussusceptive angiogenesis. First, the two opposing capillary walls establish a zone of contact. Second, the <a href="../../../e/n/d/Endothelial.html" title="Endothelial">endothelial</a> cell junctions are reorganized and the vessel bilayer is perforated to allow growth factors and cells to penetrate into the lumen. Third, a core is formed between the two new vessels at the zone of contact that is filled with <a href="../../../p/e/r/Pericyte.html" title="Pericyte">pericytes</a> and <a href="../../../m/y/o/Myofibroblast.html" title="Myofibroblast">myofibroblasts</a>. These cells begin laying collagen fibers into the core to provide an extracellular matrix for growth of the vessel lumen. Finally, the core is fleshed out with no alterations to the basic structure. Intussusception is important because it is a reorganization of existing cells. It allows a vast increase in the number of capillaries without a corresponding increase in the number of endothelial cells. This is especially important in embryonic development as there are not enough resources to create a rich microvasculature with new cells every time a new vessel develops.</p>
<p><a name="Therapeutic_angiogenesis" id="Therapeutic_angiogenesis"></a></p>
<h3><span class="editsection">[<a href="../../../a/n/g/Angiogenesis.html" title="Edit section: Therapeutic angiogenesis">edit</a>]</span> <span class="mw-headline">Therapeutic angiogenesis</span></h3>
<p>Therapeutic angiogenesis is the application of specific compounds which may inhibit or induce the creation of new blood vessels in the body in order to combat disease. The presence of blood vessels where there should be none may affect the mechanical properties of a tissue, increasing the likelihood of failure. The absence of blood vessels in a repairing or otherwise metabolically active tissue may retard repair or some other function. Several diseases (eg. <a href="../../../i/s/c/Ischemia.html" title="Ischemia">ischemic chronic wounds</a>) are the result of failure or insufficient blood vessel formation and may be treated by a local expansion of blood vessels, thus bringing new nutrients to the site, facilitating repair. Other diseases, such as age-related macular degeneration, may be created by a local expansion of blood vessels, interfering with normal physiological processes.</p>
<p><a name="Mechanical_stimulation" id="Mechanical_stimulation"></a></p>
<h2><span class="editsection">[<a href="../../../a/n/g/Angiogenesis.html" title="Edit section: Mechanical stimulation">edit</a>]</span> <span class="mw-headline">Mechanical stimulation</span></h2>
<p>Mechanical stimulation of angiogenesis is not well characterized. There is a significant amount of controversy with regard to shear stress acting on capillaries to cause angiogenesis, although current knowledge suggests that increased muscle contractions may increase angiogenesis<sup id="_ref-Prior2004_0" class="reference"><a href="#_note-Prior2004" title="">[2]</a></sup>. This may be due to an increase in the production of nitric oxide during exercise.</p>
<p><a name="Stimulation_by_protein_growth_factors" id="Stimulation_by_protein_growth_factors"></a></p>
<h2><span class="editsection">[<a href="../../../a/n/g/Angiogenesis.html" title="Edit section: Stimulation by protein growth factors">edit</a>]</span> <span class="mw-headline">Stimulation by protein growth factors</span></h2>
<p><a name="VEGF" id="VEGF"></a></p>
<h3><span class="editsection">[<a href="../../../a/n/g/Angiogenesis.html" title="Edit section: VEGF">edit</a>]</span> <span class="mw-headline">VEGF</span></h3>
<p><a href="../../../v/e/g/VEGF_3a4e.html" title="VEGF">VEGF</a> (Vascular Endothelial Growth Factor) has been demonstrated to be a major contributor to angiogenesis, increasing the number of capillaries in a given network. Initial in vitro studies demonstrated that bovine capillary endothelial cells will proliferate and show signs of tube structures upon stimulation by VEGF and <a href="../../../b/f/g/BFGF_0903.html" title="BFGF">bFGF</a>, although the results were more pronounced with VEGF<sup id="_ref-Goto1993_0" class="reference"><a href="#_note-Goto1993" title="">[3]</a></sup>. Upregulation of VEGF is a major component of the physiological response to exercise and its role in angiogenesis is suspected to be a possible treatment in vascular injuries<sup id="_ref-Ding2004_0" class="reference"><a href="#_note-Ding2004" title="">[4]</a></sup><sup id="_ref-Gavin2004_0" class="reference"><a href="#_note-Gavin2004" title="">[5]</a></sup><sup id="_ref-Kraus2004_0" class="reference"><a href="#_note-Kraus2004" title="">[6]</a></sup><sup id="_ref-Lloyd2003_0" class="reference"><a href="#_note-Lloyd2003" title="">[7]</a></sup>. In vitro studies clearly demonstrate that VEGF is a potent stimulator of angiogenesis because in the presence of this growth factor plated endothelial cells will proliferate and migrate, eventually forming tube structures resembling capillaries.<sup id="_ref-Prior2004_1" class="reference"><a href="#_note-Prior2004" title="">[2]</a></sup> <a href="../../../v/e/g/VEGF_3a4e.html" title="VEGF">VEGF</a> causes a massive signaling cascade in <a href="../../../e/n/d/Endothelium.html" title="Endothelium">endothelial</a> cells. Binding to VEGF receptor-2 (VEGFR-2) starts a tyrosine kinase signaling cascade that stimulates the production of factors that variously stimulate vessel permeability (eNOS, producting NO), proliferation/survival (bFGF), migration (ICAMs/VCAMs/MMPs) and finally differentiation into mature blood vessels. Mechanically, VEGF is upregulated with muscle contractions as a result of increased blood flow to affected areas. The increased flow also causes a large increase in the <a href="../../../m/r/n/MRNA_210c.html" title="MRNA">mRNA</a> production of VEGF receptors 1 and 2. The increase in receptor production means that muscle contractions could cause upregulation of the signaling cascade relating to angiogenesis. As part of the angiogenic signaling cascade, NO is widely considered to be a major contributor to the angiogenic response because inhibition of NO significantly reduces the effects of angiogenic growth factors. However, inhibition of NO during exercise does not inhibit angiogenesis indicating that there are other factors involved in the angiogenic response.<sup id="_ref-Prior2004_2" class="reference"><a href="#_note-Prior2004" title="">[2]</a></sup></p>
<p><a name="ANGIOPOIETINS" id="ANGIOPOIETINS"></a></p>
<h3><span class="editsection">[<a href="../../../a/n/g/Angiogenesis.html" title="Edit section: ANGIOPOIETINS">edit</a>]</span> <span class="mw-headline">ANGIOPOIETINS</span></h3>
<p>The <a href="../../../a/n/g/Angiopoietins.html" title="Angiopoietins">angiopoietins</a>, Ang1 and Ang2, are required for the formation of mature blood vessels, as demonstrated by mouse <a href="../../../k/n/o/Knock_out.html" title="Knock out">knock out</a> studies <sup id="_ref-Thurston2003_0" class="reference"><a href="#_note-Thurston2003" title="">[8]</a></sup>. <a href="../../../a/n/g/Ang1.html" title="Ang1">Ang1</a> and <a href="../../../a/n/g/Ang2.html" title="Ang2">Ang2</a> are protein growth factors which act by binding their receptors, <a href="../../../t/i/e/Tie-1.html" title="Tie-1">Tie-1</a> and <a href="../../../t/i/e/Tie-2.html" title="Tie-2">Tie-2</a>; while this is somewhat controversial, it seems that cell signals are transmitted mostly by <a href="../../../t/i/e/Tie-2.html" title="Tie-2">Tie-2</a>; though some papers show physiologic signaling via <a href="../../../t/i/e/Tie-1.html" title="Tie-1">Tie-1</a> as well. These receptors are <a href="../../../t/y/r/Tyrosine_kinases.html" title="Tyrosine kinases">tyrosine kinases</a>, thus they initiate cell signaling by dimerizing as a result of ligand binding, initiating <a href="../../../p/h/o/Phosphorylation.html" title="Phosphorylation">phosphorylation</a> on key tyrosines - this initiates <a href="../../../c/e/l/Cell_signaling.html" title="Cell signaling">cell signaling</a>.</p>
<p><a name="MMP" id="MMP"></a></p>
<h3><span class="editsection">[<a href="../../../a/n/g/Angiogenesis.html" title="Edit section: MMP">edit</a>]</span> <span class="mw-headline">MMP</span></h3>
<p>Another major contributor to angiogenesis is matrix metalloproteinase (<a href="../../../m/m/p/MMP_6fe6.html" title="MMP">MMP</a>). <a href="../../../m/m/p/MMP_6fe6.html" title="MMP">MMPs</a> help degrade the proteins that keep the vessel walls solid. This proteolysis allows the <a href="../../../e/n/d/Endothelial_cell.html" title="Endothelial cell">endothelial cells</a> to escape into the interstitial matrix as seen in sprouting angiogenesis. Inhibition of <a href="../../../m/m/p/MMP_6fe6.html" title="MMP">MMPs</a> prevents the formation of new <a href="../../../c/a/p/Capillaries.html" title="Capillaries">capillaries</a><sup id="_ref-Haas2000_0" class="reference"><a href="#_note-Haas2000" title="">[9]</a></sup>. These <a href="../../../e/n/z/Enzyme.html" title="Enzyme">enzymes</a> are highly regulated during the vessel formation process because destruction of the <a href="../../../e/x/t/Extracellular_matrix.html" title="Extracellular matrix">extracellular matrix</a> would decrease the integrity of the microvasculature.<sup id="_ref-Prior2004_3" class="reference"><a href="#_note-Prior2004" title="">[2]</a></sup></p>
<p><a name="FGF" id="FGF"></a></p>
<h3><span class="editsection">[<a href="../../../a/n/g/Angiogenesis.html" title="Edit section: FGF">edit</a>]</span> <span class="mw-headline">FGF</span></h3>
<dl>
<dd><i>Further information: <a href="../../../f/i/b/Fibroblast_Growth_Factor_b563.html" title="Fibroblast Growth Factor">Fibroblast Growth Factor</a></i></dd>
</dl>
<p>One of the most important functions of fibroblast growth factor-2 (FGF2) is the promotion of endothelial cell proliferation and the physical organization of endothelial cells into tube-like structures. It thus promotes angiogenesis, the growth of new blood vessels from the pre-existing vasculature. FGF2 is a more potent angiogenic factor than VEGF or PDGF (<a href="../../../p/l/a/Platelet-derived_growth_factor.html" title="Platelet-derived growth factor">platelet-derived growth factor</a>). As well as stimulating blood vessel growth, bFGF is an important player in wound healing. It stimulates the proliferation of fibroblasts that give rise to granulation tissue, which fills up a wound space/cavity early in the wound healing process.</p>
<p><a name="DII4" id="DII4"></a></p>
<h3><span class="editsection">[<a href="../../../a/n/g/Angiogenesis.html" title="Edit section: DII4">edit</a>]</span> <span class="mw-headline">DII4</span></h3>
<p>DII4 (Delta-like ligand 4), is a recently discovered protein <a href="../../../g/r/o/Growth_factor.html" title="Growth factor">growth factor</a> with important angiogenic properties similar to VEGF.<sup id="_ref-0" class="reference"><a href="#_note-0" title="">[10]</a></sup>. DLL4 is a transmembrane ligand, for the <a href="../../../n/o/t/Notch_family_of_receptors.html" title="Notch family of receptors">Notch family of receptors</a>.</p>
<p><a name="Applications_of_Angiogenesis" id="Applications_of_Angiogenesis"></a></p>
<h2><span class="editsection">[<a href="../../../a/n/g/Angiogenesis.html" title="Edit section: Applications of Angiogenesis">edit</a>]</span> <span class="mw-headline">Applications of Angiogenesis</span></h2>
<p><a name="Tumor_angiogenesis" id="Tumor_angiogenesis"></a></p>
<h3><span class="editsection">[<a href="../../../a/n/g/Angiogenesis.html" title="Edit section: Tumor angiogenesis">edit</a>]</span> <span class="mw-headline">Tumor angiogenesis</span></h3>
<p><a href="../../../c/a/n/Cancer.html" title="Cancer">Cancer</a> <a href="../../../c/e/l/Cell_%28biology%29.html" title="Cell (biology)">cells</a> are cells that have lost control of their ability to divide in a controlled fashion. A tumor consists of a population of rapidly dividing and growing cancer cells. <a href="../../../m/u/t/Mutation.html" title="Mutation">Mutations</a> rapidly accrue within the population. These mutations (variation) allow the cancer cells (or sub-populations of cancer cells within a tumor) to develop <a href="../../../d/r/u/Drug_resistance.html" title="Drug resistance">drug resistance</a> and escape therapy. Tumors cannot grow beyond a certain size, generally 1-2 mm³, due to a lack of oxygen and other essential nutrients.</p>
<p>Tumors induce blood vessel growth (angiogenesis) by secreting various growth factors (e.g. Vascular Endothelial Growth Factor or <a href="../../../v/e/g/VEGF_3a4e.html" title="VEGF">VEGF</a>). Growth factors, such as <a href="../../../b/f/g/BFGF_0903.html" title="BFGF">bFGF</a> and VEGF can induce capillary growth into the tumor, which some researchers suspect supply required nutrients -- allowing for tumor expansion. Other clinicians believe that angiogenesis really serves as a waste pathway, taking away the biological end products put out by rapidly dividing cancer cells. In either case, angiogenesis is a necessary and required step for transition from a small harmless cluster of cells, often said to be about the size of the metal ball at the end of a ball-point pen, to a large tumor. Angiogenesis is also required for the spread of a tumor, or <a href="../../../m/e/t/Metastasis.html" title="Metastasis">metastasis</a>. Single cancer cells can break away from an established solid tumor, enter the blood vessel, and be carried to a distant site, where they can implant and begin the growth of a secondary tumor. Evidence now suggests that the blood vessel in a given solid tumor may in fact be mosaic vessels, comprised of <a href="../../../e/n/d/Endothelium.html" title="Endothelium">endothelial cells</a> and tumor cells. This mosaicity allows for substantial shedding of tumor cells into the vasculature. The subsequent growth of such metastases will also require a supply of nutrients and <a href="../../../o/x/y/Oxygen.html" title="Oxygen">oxygen</a> or a waste disposal pathway.</p>
<p>Endothelial cells have long been considered genetically more stable than cancer cells. This genomic stability confers an advantage to targeting endothelial cells using antiangiogenic therapy, compared to chemotherapy directed at cancer cells, which rapidly mutate and acquire 'drug resistance' to treatment. For this reason, endothelial cells are thought to be an ideal target for therapies directed against them. Recent studies by Klagsbrun, et. al. have shown, however, that endothelial cells growing within tumors do carry genetic abnormalities. Thus, tumor vessels have the theoretical potential for developing acquired resistance to drugs. This is a new area of angiogenesis research being actively pursued.</p>
<p>Angiogenesis research is a cutting edge field in <a href="../../../c/a/n/Cancer_research.html" title="Cancer research">cancer research</a>, and recent evidence also suggests that traditional therapies, such as radiation therapy, may actually work in part by targeting the genomically stable endothelial cell compartment, rather than the genomicaly unstable tumor cell compartment. New blood vessel formation is a relatively fragile process, subject to disruptive interference at several levels. In short, the therapy is the selection agent which is being used to kill a cell compartment. Tumor cells evolve resistance rapidly due to rapid generation time (days) and genomic instability (variation), whereas endothelial cells are a good target because of a long generation time (months) and genomic stability (low variation).</p>
<p>This is an example of <a href="../../../s/e/l/Selection.html" title="Selection">selection</a> in action at the cellular level, using a selection pressure to target and differentiate between varying populations of cells. The end result is the <a href="../../../e/x/t/Extinction.html" title="Extinction">extinction</a> of one species or population of cells (endothelial cells), followed by the collapse of the <a href="../../../e/c/o/Ecosystem.html" title="Ecosystem">ecosystem</a> (the tumor) due either to nutrient deprivation or self-pollution from the destruction of necessary waste pathways.</p>
<p>Angiogenesis-based tumour therapy relies on natural and synthetic <a href="../../../a/n/g/Angiogenesis_inhibitor.html" title="Angiogenesis inhibitor">angiogenesis inhibitors</a> like <a href="../../../a/n/g/Angiostatin.html" title="Angiostatin">angiostatin</a>, <a href="../../../e/n/d/Endostatin.html" title="Endostatin">endostatin</a> and tumstatin. These are <a href="../../../p/r/o/Protein.html" title="Protein">proteins</a> that mainly originate as specific fragments pre-existing structural proteins like <a href="../../../c/o/l/Collagen.html" title="Collagen">collagen</a> or <a href="../../../p/l/a/Plasminogen.html" title="Plasminogen">plasminogen</a>.</p>
<p>Recently, the 1st FDA-approved therapy targeted at angiogenesis in cancer came on the market in the US. This is a monoclonal antibody directed against an isoform of VEGF. The commercial name of this antibody is <a href="../../../a/v/a/Avastin.html" title="Avastin">Avastin</a>, and the therapy has been approved for use in colorectal cancer in combination with established chemotherapy.</p>
<p><a name="Exercise" id="Exercise"></a></p>
<h3><span class="editsection">[<a href="../../../a/n/g/Angiogenesis.html" title="Edit section: Exercise">edit</a>]</span> <span class="mw-headline">Exercise</span></h3>
<p>Angiogenesis is generally associated with <a href="../../../a/e/r/Aerobic_exercise.html" title="Aerobic exercise">aerobic exercise</a> and endurance exercise. While <a href="../../../a/r/t/Arteriogenesis.html" title="Arteriogenesis">arteriogenesis</a> produces network changes that allow for a large increase in the amount of total flow in a network, angiogenesis causes changes that allow for greater nutrient delivery over a long period of time. Capillaries are designed to provide maximum nutrient delivery efficiency so an increase in the number of capillaries allows the network to deliver more nutrients in the same amount of time. A greater number of capillaries also allows for greater oxygen exchange in the network. This is vitally important to endurance training because it allows a person to continue training for an extended period of time. However, no experimental evidence exists to suggest that increased capillarity is required in endurance exercise to increase the maximum oxygen delivery.<sup id="_ref-Prior2004_4" class="reference"><a href="#_note-Prior2004" title="">[2]</a></sup></p>
<p><a name="Macular_degeneration" id="Macular_degeneration"></a></p>
<h3><span class="editsection">[<a href="../../../a/n/g/Angiogenesis.html" title="Edit section: Macular degeneration">edit</a>]</span> <span class="mw-headline">Macular degeneration</span></h3>
<p>Overexpression of VEGF causes increased permeability in blood vessels in addition to stimulating angiogenesis. In wet <a href="../../../m/a/c/Macular_degeneration.html" title="Macular degeneration">macular degeneration</a> VEGF causes proliferation of capillaries into the retina. Since the increase in angiogenesis also causes <a href="../../../e/d/e/Edema.html" title="Edema">edema</a>, blood and other retinal fluids leak into the retina causing loss of vision. A novel treatment of this disease is to use a VEGF inhibiting <a href="../../../s/i/r/SiRNA_8dff.html" title="SiRNA">siRNA</a> to stop the main signaling cascade for angiogenesis.</p>
<p><a name="See_also" id="See_also"></a></p>
<h2><span class="editsection">[<a href="../../../a/n/g/Angiogenesis.html" title="Edit section: See also">edit</a>]</span> <span class="mw-headline">See also</span></h2>
<ul>
<li><a href="../../../a/r/t/Arteriogenesis.html" title="Arteriogenesis">arteriogenesis</a></li>
<li>endurance exercise</li>
<li><a href="../../../a/e/r/Aerobic_exercise.html" title="Aerobic exercise">aerobic exercise</a></li>
</ul>
<p><a name="References" id="References"></a></p>
<h2><span class="editsection">[<a href="../../../a/n/g/Angiogenesis.html" title="Edit section: References">edit</a>]</span> <span class="mw-headline">References</span></h2>
<div class="references-small" style="-moz-column-count:2; column-count:2;">
<ol class="references">
<li id="_note-Burri2004"><b><a href="#_ref-Burri2004_0" title="">^</a></b> <cite style="font-style:normal">Burri, PH (2004). "Intussusceptive angiogenesis: its emergence, its characteristics, and its significance.". <i>Dev Dyn.</i> <b>231(3)</b>: 474-88.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Intussusceptive+angiogenesis%3A+its+emergence%2C+its+characteristics%2C+and+its+significance.&amp;rft.title=Dev+Dyn.&amp;rft.jtitle=Dev+Dyn.&amp;rft.date=2004&amp;rft.volume=231%283%29&amp;rft.aulast=Burri&amp;rft.aufirst=PH&amp;rft.pages=474-88">&#160;</span></li>
<li id="_note-Prior2004">^ <a href="#_ref-Prior2004_0" title=""><sup><i><b>a</b></i></sup></a> <a href="#_ref-Prior2004_1" title=""><sup><i><b>b</b></i></sup></a> <a href="#_ref-Prior2004_2" title=""><sup><i><b>c</b></i></sup></a> <a href="#_ref-Prior2004_3" title=""><sup><i><b>d</b></i></sup></a> <a href="#_ref-Prior2004_4" title=""><sup><i><b>e</b></i></sup></a> Prior, B. M., Yang, H. T., &amp; Terjung, R. L. What makes vessels grow with exercise training? J App Physiol 97: 1119-28, 2004</li>
<li id="_note-Goto1993"><b><a href="#_ref-Goto1993_0" title="">^</a></b> Goto, F., Goto, K., Weindel, K., &amp; Folkman, J. Synergistic effects of vascular endothelial growth-factor and basic fibroblast growth factor on the proliferation and cord formation of bovine capillary endothelial cells within collagen gels. Lab Inves 69: 508-17, 1993</li>
<li id="_note-Ding2004"><b><a href="#_ref-Ding2004_0" title="">^</a></b> Ding, Y. H., Luan, X. D., Li, J., Rafols, J. A., Guthinkonda, M., &amp; Diaz, F. G. et al. Exercise-induced overexpression of angiogenic factors and reduction of ischemia/reperfusion injury in stroke. Curr Neurovasc Res 1: 411-20, 2004</li>
<li id="_note-Gavin2004"><b><a href="#_ref-Gavin2004_0" title="">^</a></b> Gavin, T. P., Robinson, C. B., Yeager, R. C., England, J. A., Nifong, L. W., &amp; Hickner, R. C. Angiogenic growth factor response to acute systemic exercise in human skeletal muscle. J App Physiol 96: 19-24, 2004</li>
<li id="_note-Kraus2004"><b><a href="#_ref-Kraus2004_0" title="">^</a></b> Kraus, R. M., Stallings, H. W., Yeager, R. C., &amp; Gavin, T. P. Circulating plasma VEGF response to exercise in sedentary and endurance-trained men. J App Physiol 96: 1445-50, 2004.</li>
<li id="_note-Lloyd2003"><b><a href="#_ref-Lloyd2003_0" title="">^</a></b> Lloyd, P. G., Prior, B. M., Yang, H. T., &amp; Terjung, R. L. Angiogenic growth factor expression in rat skeletal muscle in response to exercise training. Am J Physiol Heart Circ Physiol 284: 1668-78, 2003.</li>
<li id="_note-Thurston2003"><b><a href="#_ref-Thurston2003_0" title="">^</a></b> Thurston G. Role of Angiopoietins and Tie receptor tyrosine kinases in angiogenesis and lymphangiogenesis. Cell Tissue Res. 2003 Oct;314(1):61-8. Epub 2003 Aug 12.</li>
<li id="_note-Haas2000"><b><a href="#_ref-Haas2000_0" title="">^</a></b> Haas, T. L., Milkiewicz, M., Davis, S. J., Zhou, A. L., Egginton, S., Brown, M. D., Madri, J. A., Hudlicka, O. Matrix metalloproteinase activity is required for activity-induced angiogenesis in rat skeletal muscle. Am J Physiol Heart Circ Physiol 279: H1540-H1547, 2000</li>
<li id="_note-0"><b><a href="#_ref-0" title="">^</a></b> , Lobov IB, Renard RA, Papadopoulos N, Gale NW, Thurston G, Yancopoulos GD, Wiegand SJ. (2007) Proc Natl Acad Sci U S A. 2007 104(9):3219-24. Epub 2007 Feb 12.</li>
</ol>
</div>
<p><a name="External_links" id="External_links"></a></p>
<h2><span class="editsection">[<a href="../../../a/n/g/Angiogenesis.html" title="Edit section: External links">edit</a>]</span> <span class="mw-headline">External links</span></h2>
<ul>
<li><a href="http://www.ptca.org/angiogenesis.html" class="external text" title="http://www.ptca.org/angiogenesis.html" rel="nofollow">Angiogenesis for Heart Disease from Angioplasty.Org</a></li>
<li><a href="http://cancerguide.org/basic.html" class="external text" title="http://cancerguide.org/basic.html" rel="nofollow">What You Need to Get Started Researching Your Options</a> from <a href="http://cancerguide.org/" class="external text" title="http://cancerguide.org/" rel="nofollow">CancerGuide</a></li>
<li><a href="http://www.biochemweb.org/angiogenesis.shtml" class="external text" title="http://www.biochemweb.org/angiogenesis.shtml" rel="nofollow">Angiogenesis - The Virtual Library of Biochemistry and Cell Biology</a></li>
<li><a href="http://www.nci.nih.gov/cancertopics/understandingcancer/angiogenesis/allpages" class="external text" title="http://www.nci.nih.gov/cancertopics/understandingcancer/angiogenesis/allpages" rel="nofollow">NCI Understanding Cancer series on Angiogenesis</a></li>
<li><a href="http://www.therapeuticangiogenesis.com" class="external text" title="http://www.therapeuticangiogenesis.com" rel="nofollow">TherapeuticAngiogenesis.com</a></li>
<li><a href="http://www.angio.org" class="external text" title="http://www.angio.org" rel="nofollow">Angiogenesis Foundation</a></li>
</ul>

<!-- 
Pre-expand include size: 5593 bytes
Post-expand include size: 1455 bytes
Template argument size: 953 bytes
Maximum: 2048000 bytes
-->
<div class="printfooter">
Retrieved from "<a href="http://en.wikipedia.org../../../a/n/g/Angiogenesis.html">http://en.wikipedia.org../../../a/n/g/Angiogenesis.html</a>"</div>
	    <div id="catlinks"><p class='catlinks'><a href="../../../c/a/t/Special%7ECategories_101d.html" title="Special:Categories">Category</a>: <span dir='ltr'><a href="../../../a/n/g/Category%7EAngiology_2155.html" title="Category:Angiology">Angiology</a></span></p></div>	    <!-- end content -->
	    <div class="visualClear"></div>
	  </div>
	</div>
      </div>
      <div id="column-one">
	<div id="p-cactions" class="portlet">
	  <h5>Views</h5>
	  <ul>
	    <li id="ca-nstab-main"
	       class="selected"	       ><a href="../../../a/n/g/Angiogenesis.html">Article</a></li><li id="ca-talk"
	       	       ><a href="../../../a/n/g/Talk%7EAngiogenesis_e80b.html">Discussion</a></li><li id="ca-current"
	       	       ><a href="http://en.wikipedia.org/wiki/Angiogenesis">Current revision</a></li>	  </ul>
	</div>
	<div class="portlet" id="p-logo">
	  <a style="background-image: url(../../../images/wiki-en.png);"
	    href="../../../index.html"
	    title="Main Page"></a>
	</div>
	<script type="text/javascript"> if (window.isMSIE55) fixalpha(); </script>
		<div class='portlet' id='p-navigation'>
	  <h5>Navigation</h5>
	  <div class='pBody'>
	    <ul>
	    	      <li id="n-Main-page"><a href="../../../index.html">Main page</a></li>
	     	      <li id="n-Contents"><a href="../../../c/o/n/Wikipedia%7EContents_3181.html">Contents</a></li>
	     	      <li id="n-Featured-content"><a href="../../../f/e/a/Wikipedia%7EFeatured_content_24ba.html">Featured content</a></li>
	     	      <li id="n-currentevents"><a href="../../../c/u/r/Portal%7ECurrent_events_bb60.html">Current events</a></li>
	     	    </ul>
	  </div>
	</div>
		<div class='portlet' id='p-interaction'>
	  <h5>interaction</h5>
	  <div class='pBody'>
	    <ul>
	    	      <li id="n-About-Wikipedia"><a href="../../../a/b/o/Wikipedia%7EAbout_8d82.html">About Wikipedia</a></li>
	     	      <li id="n-portal"><a href="../../../c/o/m/Wikipedia%7ECommunity_Portal_6a3c.html">Community portal</a></li>
	     	      <li id="n-contact"><a href="../../../c/o/n/Wikipedia%7EContact_us_afd6.html">Contact us</a></li>
	     	      <li id="n-sitesupport"><a href="http://wikimediafoundation.org/wiki/Fundraising">Make a donation</a></li>
	     	      <li id="n-help"><a href="../../../c/o/n/Help%7EContents_22de.html">Help</a></li>
	     	    </ul>
	  </div>
	</div>
		<div id="p-search" class="portlet">
	  <h5><label for="searchInput">Search</label></h5>
	  <div id="searchBody" class="pBody">
	    <form action="javascript:goToStatic(3)" id="searchform"><div>
	      <input id="searchInput" name="search" type="text"
	        accesskey="f" value="" />
	      <input type='submit' name="go" class="searchButton" id="searchGoButton"
	        value="Go" />
	    </div></form>
	  </div>
	</div>
	<div id="p-lang" class="portlet">
	  <h5>In other languages</h5>
	  <div class="pBody">
	    <ul>
	      	      <li>
	      <a href="../../../../de/a/n/g/Angiogenese.html">Deutsch</a>
	      </li>
	      	      <li>
	      <a href="../../../../es/a/n/g/Angiog%C3%A9nesis.html">Español</a>
	      </li>
	      	      <li>
	      <a href="../../../../he/%D7%90/%D7%A0/%D7%92/%D7%90%D7%A0%D7%92%D7%99%D7%95%D7%92%D7%A0%D7%96%D7%94.html">עברית</a>
	      </li>
	      	      <li>
	      <a href="../../../../nl/a/n/g/Angiogenese.html">Nederlands</a>
	      </li>
	      	      <li>
	      <a href="../../../../pl/a/n/g/Angiogeneza.html">Polski</a>
	      </li>
	      	      <li>
	      <a href="../../../../pt/a/n/g/Angiog%C3%AAnese.html">Português</a>
	      </li>
	      	      <li>
	      <a href="../../../../sv/a/n/g/Angiogenes.html">Svenska</a>
	      </li>
	      	      <li>
	      <a href="../../../../ru/%D0%B0/%D0%BD/%D0%B3/%D0%90%D0%BD%D0%B3%D0%B8%D0%BE%D0%B3%D0%B5%D0%BD%D0%B5%D0%B7.html">Русский</a>
	      </li>
	      	    </ul>
	  </div>
	</div>
	      </div><!-- end of the left (by default at least) column -->
      <div class="visualClear"></div>
      <div id="footer">
    <div id="f-poweredbyico"><a href="http://www.mediawiki.org/"><img src="../../../skins/common/images/poweredby_mediawiki_88x31.png" alt="Powered by MediaWiki" /></a></div>	<div id="f-copyrightico"><a href="http://wikimediafoundation.org/"><img src="../../../images/wikimedia-button.png" border="0" alt="Wikimedia Foundation"/></a></div>	<ul id="f-list">
	  	  	  <li id="f-credits">This page was last modified 13:43, 29 March 2007 by Wikipedia user <a href="../../../g/a/c/User%7EGacggt_5e20.html" title="User:Gacggt">Gacggt</a>. Based on work by Wikipedia user(s) Tfarlow, <a href="../../../j/e/f/User%7EJeffreyN_9725.html" title="User:JeffreyN">JeffreyN</a>, <a href="../../../n/s/o/User%7ENsoltani_b85f.html" title="User:Nsoltani">Nsoltani</a>, <a href="../../../e/v/e/User%7EEveryking_5c9e.html" title="User:Everyking">Everyking</a>, <a href="../../../j/a/r/User%7EJarfingle_2eaa.html" title="User:Jarfingle">Jarfingle</a>, <a href="../../../j/o/n/User%7EJonHarder_ef53.html" title="User:JonHarder">JonHarder</a>, <a href="../../../k/j/a/User%7EKjaergaard_efff.html" title="User:Kjaergaard">Kjaergaard</a>, Docstar, MAB123, <a href="../../../b/l/u/User%7EBluebot_e595.html" title="User:Bluebot">Bluebot</a>, <a href="../../../j/l/i/User%7EJlittlet_048e.html" title="User:Jlittlet">Jlittlet</a>, Danfamily, <a href="../../../y/u/r/User%7EYurikBot_b393.html" title="User:YurikBot">YurikBot</a>, Zgaimalo, Bioxpert, <a href="../../../o/a/s/User%7EOasisbob_0980.html" title="User:Oasisbob">Oasisbob</a>, <a href="../../../t/h/i/User%7EThijs%21bot_bdf4.html" title="User:Thijs!bot">Thijs!bot</a>, <a href="../../../r/e/b/User%7ERebelguys2_63db.html" title="User:Rebelguys2">Rebelguys2</a>, <a href="../../../s/h/e/User%7EShenme_67cd.html" title="User:Shenme">Shenme</a>, <a href="../../../b/o/r/User%7EBorgHunter_70c9.html" title="User:BorgHunter">BorgHunter</a>, <a href="../../../w/i/k/User%7EWikiborg_3c13.html" title="User:Wikiborg">Wikiborg</a>, <a href="../../../k/a/z/User%7EKazkaskazkasako_ef67.html" title="User:Kazkaskazkasako">Kazkaskazkasako</a>, SvenskaJohannes, Xwingjedi14, <a href="../../../f/l/a/User%7EFlaBot_747f.html" title="User:FlaBot">FlaBot</a>, <a href="../../../w/o/u/User%7EWouterstomp_b006.html" title="User:Wouterstomp">Wouterstomp</a>, <a href="../../../f/l/c/User%7EFlcelloguy_1bb8.html" title="User:Flcelloguy">Flcelloguy</a>, Carax, <a href="../../../j/p/b/User%7EJpbrody_d54f.html" title="User:Jpbrody">Jpbrody</a>, <a href="../../../w/o/b/User%7EWobble_51f3.html" title="User:Wobble">Wobble</a>, <a href="../../../n/u/n/User%7ENuno_Tavares_6b5f.html" title="User:Nuno Tavares">Nuno Tavares</a>, <a href="../../../h/a/d/User%7EHadal_a4d0.html" title="User:Hadal">Hadal</a>, GFP, <a href="../../../c/d/n/User%7ECDN99_e864.html" title="User:CDN99">CDN99</a>, <a href="../../../b/r/y/User%7EBryan_Derksen_3ce8.html" title="User:Bryan Derksen">Bryan Derksen</a>, Pabloes, PP Jewel, <a href="../../../t/h/u/User%7EThue_a090.html" title="User:Thue">Thue</a>, <a href="../../../p/f/h/User%7EPFHLai_0319.html" title="User:PFHLai">PFHLai</a> and <a href="../../../w/m/a/User%7EWmahan_ede0.html" title="User:Wmahan">Wmahan</a> and Anonymous user(s) of Wikipedia.</li>	  <li id="f-copyright">All text is available under the terms of the <a class='internal' href="../../../t/e/x/Wikipedia%7EText_of_the_GNU_Free_Documentation_License_702a.html" title="Wikipedia:Text of the GNU Free Documentation License">GNU Free Documentation License</a>. (See <b><a class='internal' href="../../../c/o/p/Wikipedia%7ECopyrights_92c4.html" title="Wikipedia:Copyrights">Copyrights</a></b> for details.) <br /> Wikipedia&reg; is a registered trademark of the <a href="http://www.wikimediafoundation.org">Wikimedia Foundation, Inc</a>., a US-registered <a class='internal' href="../../../5/0/1/501%28c%29.html#501.28c.29.283.29" title="501(c)(3)">501(c)(3)</a> <a href="http://wikimediafoundation.org/wiki/Deductibility_of_donations">tax-deductible</a> <a class='internal' href="../../../n/o/n/Non-profit_organization.html" title="Non-profit organization">nonprofit</a> <a href="../../../c/h/a/Charitable_organization.html" title="Charitable organization">charity</a>.<br /></li>	  <li id="f-about"><a href="../../../a/b/o/Wikipedia%7EAbout_8d82.html" title="Wikipedia:About">About Wikipedia</a></li>	  <li id="f-disclaimer"><a href="../../../g/e/n/Wikipedia%7EGeneral_disclaimer_3e44.html" title="Wikipedia:General disclaimer">Disclaimers</a></li>	  	</ul>
      </div>
    </div>
  </body>
</html>
